Prednisolone for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Prednisolone is a prescription corticosteroid used to reduce inflammation and calm an overactive immune response in horses. It belongs to the glucocorticoid family, the same broad drug class as dexamethasone and prednisone. In equine medicine, vets often choose prednisolone rather than prednisone because horses do not reliably convert prednisone into the active form.

This medication can be very helpful when inflammation is driving a horse's symptoms, but it is not a casual drug. Corticosteroids can affect the immune system, metabolism, and the horse's natural steroid balance. That is why your vet may recommend bloodwork, careful tapering, or extra monitoring in horses with laminitis risk, equine metabolic syndrome, PPID, ulcers, or active infection.

Prednisolone is usually given by mouth as tablets or an oral liquid. It is often used for days to weeks, not as a one-time fix. In many cases, the goal is to control symptoms with the lowest effective dose for the shortest practical time, then taper gradually if the horse has been on it long enough to suppress normal adrenal function.

Your vet may prescribe prednisolone when a horse needs anti-inflammatory or immunosuppressive support. Common examples include equine asthma, allergic skin disease such as hives or hypersensitivity reactions, some inflammatory eye conditions as part of a broader treatment plan, and selected immune-mediated problems.

It may also be used in some horses with inflammatory bowel disease or other inflammatory gastrointestinal conditions. Merck lists prednisolone dosing for cats and horses in inflammatory bowel disease, which reflects its role in carefully selected equine GI cases. In these situations, prednisolone is usually only one part of the plan. Diet changes, environmental management, ulcer protection, airway management, or treatment of the underlying trigger may matter just as much.

Prednisolone is not appropriate for every swollen, itchy, coughing, or painful horse. Steroids can mask infection and may worsen some infectious diseases. If a horse has fever, draining wounds, pneumonia, corneal ulceration, or another possible infection, your vet may recommend a different path or combine treatment with close monitoring.

Prednisolone dosing in horses is case-specific. The right dose depends on the horse's body weight, the condition being treated, how severe the inflammation is, and whether the goal is anti-inflammatory control or stronger immunosuppression. Merck lists 1 to 2 mg/kg by mouth every 24 to 48 hours for horses in inflammatory bowel disease, but that does not mean every horse should receive that range.

In practice, your vet may start with a higher daily dose for a short period, then taper to the lowest dose that still controls signs. Alternate-day dosing may be used in some longer courses once the horse is stable. Stopping suddenly after prolonged use can be risky because corticosteroids can suppress the horse's normal adrenal hormone production.

For a 500 kg horse, even a modest mg/kg dose can mean a large number of tablets, so your vet may discuss formulation, compounding, or whether another corticosteroid is more practical. If you miss a dose, give it when you remember unless it is close to the next scheduled dose. Do not double up unless your vet specifically tells you to.

Because horses vary in their laminitis risk and metabolic status, dosing should be especially cautious in horses with equine metabolic syndrome, insulin dysregulation, PPID, obesity, or a prior history of laminitis.

Common corticosteroid side effects can include increased drinking and urination, increased appetite, sweating changes, mild behavior changes, and a higher risk of infection. With longer use, some horses may develop muscle wasting, delayed wound healing, or a dull hair coat. Because steroids suppress inflammation, they can also make a serious problem look quieter than it really is.

The side effect most horse pet parents worry about is laminitis. That concern is real enough that your vet should weigh it before prescribing any corticosteroid. The evidence is mixed, and risk appears to depend on the horse, dose, route, and underlying metabolic status rather than the drug name alone. Horses with PPID, equine metabolic syndrome, insulin dysregulation, obesity, or previous laminitis deserve extra caution.

Prednisolone can also increase susceptibility to bacterial, viral, fungal, or parasitic infections, and it may worsen gastric ulcer risk, especially when combined with NSAIDs. Call your vet promptly if your horse develops hoof pain, reluctance to move, shifting weight, fever, diarrhea, marked lethargy, swelling, or signs of infection while taking prednisolone.

See your vet immediately if your horse shows sudden foot soreness, a rocked-back stance, severe depression, trouble breathing, collapse, or signs of colic.

Prednisolone has several important interactions. The biggest day-to-day concern is combining it with NSAIDs such as phenylbutazone, flunixin meglumine, firocoxib, ketoprofen, or aspirin. Using a steroid and an NSAID together can raise the risk of stomach or intestinal ulceration and other complications, so your vet should direct any overlap very carefully.

Other interactions matter too. Prednisolone can reduce vaccine response, increase infection risk when used with other immunosuppressive drugs, and complicate monitoring in horses receiving medications that already stress the kidneys or GI tract. Merck also notes caution with concurrent gentamicin in horses receiving systemic corticosteroid therapy for eye disease because renal function should be monitored.

Always tell your vet about every medication, supplement, joint injection, ulcer medication, and recent dewormer your horse has received. That includes compounded products and show medications. If your horse competes, ask your vet about withdrawal guidance and governing-body medication rules, because corticosteroids can have competition implications.